Global Nanomedicine Market Size & Outlook, 2024-2030
Global nanomedicine market, 2018-2030 (US$M)
Related Markets
Global nanomedicine market highlights
- The global nanomedicine market generated a revenue of USD 190,582.0 million in 2023 and is expected to reach USD 410,151.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 11.6% by 2030.
- In terms of segment, drug delivery accounted for a revenue of USD 65,041.3 million in 2023.
- Therapeutics is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 190,582.0 million |
| Market revenue in 2030 | USD 410,151.1 million |
| Growth rate | 11.6% (CAGR from 2024 to 2030) |
| Largest segment | Drug delivery |
| Fastest growing segment | Therapeutics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Delivery, Therapeutics, In-vitro Diagnostics, Implants, In-vivo Imaging |
Other key industry trends
- In terms of revenue, the North America accounted for 50.6% of the global nanomedicine market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 23,032.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nanomedicine Market Scope
Nanomedicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc | View profile | 525 | 177 E. Colorado Boulevard, Suite 700, Pasadena, CA, United States, 91105 | https://www.arrowheadpharma.com |
| Celgene | View profile | 10001+ | Summit, New Jersey, United States, North America | https://www.bms.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Invitae Corp | View profile | 1700 | 1400 16th Street, San Francisco, CA, United States, 94103 | https://www.invitae.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Global nanomedicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nanomedicine market will help companies and investors design strategic landscapes.
Drug delivery was the largest segment with a revenue share of 34.13% in 2023. Horizon Databook has segmented the Global nanomedicine market based on drug delivery, therapeutics, in-vitro diagnostics, implants, in-vivo imaging covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in the penetration of therapeutics segment in the nanomedicine market is attributive to the rising usage of the nanotechnology in drug delivery methods. Advancements with respect to nanorobotics, which is although in the nascent stage of development holds significant potential for growth in this market.
Involvement of scientists for engineering the nanorobots for the targeting and destruction of malignant cells in the cancer patients without affecting the surrounding healthy cells is expected to support product developments in the market. Moreover, use of DNA origami for building of nano scale robots which can interact dynamically and operate through logical computations is anticipated to poise investments from technologically established players.
Henceforth, these technological breakthroughs are expected to fuel progress in the nanotechnology market. Additionally, use of photoactive nanomaterials for improvement in the targeted delivery for photodynamic therapy coupled with development of micelles and emulsions and a diverse set of nanoparticles, gold particles or polymeric particles to reduce the toxicity of harmful compounds used in oncology is attributive for the industrial growth.
Reasons to subscribe to Global nanomedicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global nanomedicine market databook
-
Our clientele includes a mix of nanomedicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global nanomedicine market , including forecasts for subscribers. This global databook contains high-level insights into Global nanomedicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global nanomedicine market size, by regions, 2018-2030 (US$M)
Top 10 countries: Nanomedicine market size, 2023 (US$M)
Global nanomedicine market share, by application, 2023 & 2030 (%, US$M)
Nanomedicine market: Opportunity assessment by country
Global nanomedicine market, by region, 2023 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
